Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art.
Sollima A, Rossini F, Lanza P, Pallotto C, Meschiari M, Gentile I, Stellini R, Lenzi A, Mulé A, Castagna F, Lorenzotti S, Amadasi S, Van Hauwermeiren E, Saccani B, Fumarola B, Signorini L, Castelli F, Matteelli A. Sollima A, et al. Among authors: mule a. Antibiotics (Basel). 2024 May 16;13(5):453. doi: 10.3390/antibiotics13050453. Antibiotics (Basel). 2024. PMID: 38786181 Free PMC article.
Metastases to the parotid glands: An institutional experience.
Calo L, Alboni T, Bruno C, Policardo F, Feraco A, Tralongo P, Vegni F, Mulè A, Brigato F, Rossi G, Bussu F, Pantanowitz L, Galli J, Rossi ED. Calo L, et al. Among authors: mule a. Cytopathology. 2024 May 16. doi: 10.1111/cyt.13387. Online ahead of print. Cytopathology. 2024. PMID: 38752464
Atypical glandular cells and predictive features of malignancy in Pap smears: A retrospective monocentric study.
Cianfrini F, d'Amati A, Arciuolo D, Travaglino A, D'Alessandris N, Scaglione G, Valente M, Urtueta BP, Addante F, Narducci N, Angelico G, Piermattei A, Mulè A, Santoro A, Rossi ED, Zannoni GF. Cianfrini F, et al. Among authors: mule a. Cytopathology. 2024 Apr 30. doi: 10.1111/cyt.13383. Online ahead of print. Cytopathology. 2024. PMID: 38686982
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Leotta S, Markovic U, Duminuco A, Mulè A, Porretto F, Federico V, Gentile M, Pastore D, Nigro LL, Selleri C, Serio B, Calafiore V, Patti C, Mauro E, Vetro C, Maugeri C, Parisi M, Fiumara P, Parrinello L, Marino S, Scuderi G, Garibaldi B, Musso M, Renzo ND, Vigna E, Martino EA, Raimondo FD, Milone G. Leotta S, et al. Among authors: mule a. Ann Hematol. 2024 Apr 13. doi: 10.1007/s00277-024-05725-9. Online ahead of print. Ann Hematol. 2024. PMID: 38609726
Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit.
Fumarola B, Signorini L, Lorenzotti S, Lanza P, Saccani B, Van Hauwermeiren E, Mulè A, Piva S, Rota M, Zuccalà F, Rasulo FA, Filippini M, Bertazzoli A, Del Fabro G, Matteelli A. Fumarola B, et al. Among authors: mule a. Infection. 2024 Mar 26. doi: 10.1007/s15010-024-02234-9. Online ahead of print. Infection. 2024. PMID: 38530518
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
Iachettini S, Terrenato I, Porru M, Di Vito S, Rizzo A, D'Angelo C, Petti E, Dinami R, Maresca C, Di Benedetto A, Palange A, Mulè A, Santoro A, Palazzo A, Fuso P, Stoppacciaro A, Vici P, Filomeno L, Di Lisa FS, Arcuri T, Krasniqi E, Fabi A, Biroccio A, Zizza P. Iachettini S, et al. Among authors: mule a. J Exp Clin Cancer Res. 2024 Mar 9;43(1):75. doi: 10.1186/s13046-024-02998-w. J Exp Clin Cancer Res. 2024. PMID: 38459559 Free PMC article.
230 results